301258 Suzhou Fushilai Pharmaceutical
- 23.61
- -0.01-0.04%
Suzhou Fushilai Pharmaceutical News
Suzhou Fushilai Pharmaceutical: Announcement about the progress of stock repurchase.
Suzhou Fushilai Pharmaceutical: Announcement of Resolution of the Thirteenth Meeting of the Fourth Board of Supervisors.
Suzhou Fushilai Pharmaceutical: Announcement on Using Partial Idle Own Funds to Invest in Securities
Suzhou Fushilai Pharmaceutical: Orient Securities Co., Ltd.'s underwriting and sponsorship subsidiary has issued an opinion on the verification of Suzhou FULAI Pharmaceutical Co., Ltd.'s use of some idle funds for securities investment.
Suzhou Fushilai Pharmaceutical: Announcement of the resolutions of the 14th meeting of the 4th board of directors.
Suzhou Fushilai Pharmaceutical: Announcement on the Progress of Using Part of the Idle Raised Funds for Cash Management
Suzhou Fushilai Pharmaceutical: Progress Announcement on Using Part of Idle Own Funds for Entrusted Wealth Management
Suzhou Fushilai Pharmaceutical: Announcement on the adjustment of the maximum repurchase price after the implementation of the 2023 annual equity distribution.
Suzhou Fushilai Pharmaceutical: Announcement about the progress of stock repurchase.
Suzhou Fushilai Pharmaceutical: Announcement of Annual Equity Distribution Implementation in 2023
Suzhou Fushilai Pharmaceutical: Legal Opinion of Shanghai Randy (Suzhou) Law Firm on the 2023 Annual General Meeting of Shareholders of Suzhou Fujilai Pharmaceutical Co., Ltd.
Suzhou Fushilai Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Suzhou Fushilai Pharmaceutical: Notice on Obtaining the Renewed “Pharmaceutical Production License”
Suzhou Fushilai Pharmaceutical: Announcement on the progress of share repurchases
Suzhou Fushilai Pharmaceutical: Notice of abnormal fluctuations in stock trading
Fujilai: Investor Relations Activity Record for April 24, 2024
Fujilai: Supervisory Board Resolutions Announcement
Fujilai: Notice on Convening the Company's 2023 Annual General Meeting of Shareholders
Fujilai: 2023 Internal Control Self-Assessment Report
Fujilai: Announcement on the proposed purchase of directors' and supervisors' liability insurance
Analysis
Price Target
No Data
